Asset Transaction Form 8 K

The information contained in the Introductory Note of this Current Report on Form 8-Kis incorporated by reference into this Item 1.02.

On January 8, 2025, in connection with the Merger (as defined below), the Company, as borrower, terminated, and Parent paid or caused to be paid, on behalf of the Company, all amounts necessary to pay and fully discharge the then-outstanding obligations of the Company under, the Loan and Security Agreement, dated as of February 22, 2022, by and among the Company, Oxford Finance LLC, as the collateral agent (the "Collateral Agent"), the lenders from time to time party thereto and Vindico NanoBioTechnology, LLC ("Vindico"), as amended by the Consent and First Amendment to the Loan and Security Agreement, dated as of July 19, 2023, by and among the Company, the Collateral Agent, the Lenders and Vindico (the "First Amendment"). The Company previously filed the Loan Agreement as Exhibit 10.23 to its Annual Report on Form 10-Kfor the year ended December 31, 2021, filed with the SEC on March 10, 2022, and the First Amendment as Exhibit 10.1 to its Quarterly Report on Form 10-Qfor the quarter ended June 30, 2023, filed with the SEC on August 8, 2023.